ライフサイエンスコーパス: suppuration

1 rways of children with chronic endobronchial suppuration.

2 sence of pain; and 4) presence or absence of suppuration.

3 involvement, bleeding on probing (BOP), and suppuration.

4 nd progressive swelling with the presence of suppuration.

5 Duration of treatment > 2 years; suppuration and dental extractions were independent risk

6 ccess at the peri-implant soft-tissue level, suppuration, and bleeding.

7 phenotypes of mononuclear cell infiltration, suppuration, and demyelination.

8 Success criteria included absence of pain, suppuration, and implant mobility; absence of continuous

9 l, gingival erythema, bleeding upon probing, suppuration, and plaque.

10 t depths >/=5 mm, bleeding at probing and/or suppuration, and the presence of implant radiographic bo

11 progressive lung inflammation with prominent suppuration, and they deteriorated clinically.

12 phic bone loss, and presence of bleeding and suppuration as rather important diagnostic criteria.

13 atient presented for routine follow-up where suppuration associated with the membrane was noted along

14 eeding on probing, probing pocket depth, and suppuration at T2 did not differ between groups (P > 0.0

15 ore Stage IV) and more frequently teeth with suppuration compared with the diabetologically inconspic

16 of keratinized mucosa, bleeding on probing, suppuration, implant mobility, plaque index, and gingiva

17 rs, including bleeding on probing, mobility, suppuration, mucosal recession, and buccal tissue transp

18 recession, mobility, bleeding on probing, or suppuration (n = 40) at 48 months.

19 lant probing depth, bleeding on probing, and suppuration on probing were evaluated and compared betwe

20 ment indexes during follow-up were recorded: suppuration on probing, modified bleeding on probing, pr

21 d, bisphosphonate use (OR = 7.2 {2.1-24.7}), suppuration (OR = 11.9 {2.0-69.5}), and extractions (OR

22 Risk markers included local suppuration (OR = 7.8 {1.8-34.1}), dental extraction (OR

23 rforated appendicitis, findings of gangrene, suppuration, or exudate are associated with increased su

24 f <2 mm versus >=2 mm, with the exception of suppuration (P = 0.6), all the clinical and radiographic

25 epths, mucosal redness, bleeding on probing, suppuration, plaque index, and marginal bone loss were r

26 Plaque, gingivitis, bleeding on probing, suppuration, probing depth, and clinical attachment leve

27 h the presence of bleeding on probing and/or suppuration), smoking status, and potential risk variabl

28 Suppuration (SUP) as a diagnostic parameter for monitori

29 Suppuration (SUP) on probing may be an indication of act

30 index (PI), BoP, PD, recession depth (REC), suppuration (SUP), and radiographically measured vertica

31 recession (REC), bleeding on probing (BOP), suppuration (SUP), and supragingival plaque (PL).

32 ding on probing (BOP), mucosal redness (MR), suppuration (SUP), keratinized mucosa dimension, and mar

33 teristics such as bleeding on probing (BOP), suppuration (SUPP), keratinized mucosa (KM), probing dep

34 group to have more postoperative abscess or suppuration than test sites (control = 11; test = 4; P =

35 ths of treatment, the patient presented with suppuration that was refractory to local efforts.

36 While the frequency of sites with suppuration was markedly reduced following all antimicro

37 isease, while increase in PD (PD > 4 mm) and suppuration were good discriminants amongst PIM/PIMP.

38 s > or = 5 mm and bleeding on probing and/or suppuration were randomized into 4 treatment groups whic

39 > 5 mm with bleeding on probing (BOP) and/or suppuration were studied.

40 10.77; 95% CI = -3.43 to 24.97; P >0.05) or suppuration (WMD = 1.77; 95% CI = -1.7 to 5.24; P >0.05)